838 related articles for article (PubMed ID: 19685461)
1. BTJ Forum: Biotech in the financial crisis.
Biotechnol J; 2009 Aug; 4(8):1108-10. PubMed ID: 19685461
[No Abstract] [Full Text] [Related]
2. The biotechnology industry: What's next?
Guertin PA
Biotechnol J; 2009 Aug; 4(8):1124-31. PubMed ID: 19685466
[No Abstract] [Full Text] [Related]
3. White biotech and the financial crisis.
Rabinovich M
Biotechnol J; 2009 Aug; 4(8):1117-23. PubMed ID: 19685465
[No Abstract] [Full Text] [Related]
4. Perspective: Biotech funding trends: Insights from entrepreneurs and investors.
Gruber AC
Biotechnol J; 2009 Aug; 4(8):1102-5. PubMed ID: 19685460
[TBL] [Abstract][Full Text] [Related]
5. Perspective: A tale of 'cautious pessimism': Biotechnology, recession and the 'new economy'.
Kewell B; Webster A
Biotechnol J; 2009 Aug; 4(8):1106-8. PubMed ID: 19685467
[No Abstract] [Full Text] [Related]
6. Editorial: Biotech in the financial crisis.
Jungbauer A
Biotechnol J; 2009 Aug; 4(8):1095. PubMed ID: 19685457
[No Abstract] [Full Text] [Related]
7. OECD says industrial biotech not realizing potential.
Niiler E
Nat Biotechnol; 2001 Jun; 19(6):493-4. PubMed ID: 11385413
[No Abstract] [Full Text] [Related]
8. Biotech R&D still reeling.
Lawrence S
Nat Biotechnol; 2004 Sep; 22(9):1068. PubMed ID: 15340460
[No Abstract] [Full Text] [Related]
9. Public biotech 2006 - the numbers.
Lähteenmäki R; Lawrence S
Nat Biotechnol; 2007 Jul; 25(7):729-37. PubMed ID: 17621294
[No Abstract] [Full Text] [Related]
10. India shuts door on embryonic export market.
Jayaraman KS
Nature; 2002 Sep; 419(6904):238. PubMed ID: 12239528
[No Abstract] [Full Text] [Related]
11. The view from the top.
Howard K
Nature; 2003 Dec; 426(6967):696-7. PubMed ID: 14668873
[No Abstract] [Full Text] [Related]
12. Forming an international biotechnology spinout: is it worth it?
Christoffersen RE
Nat Biotechnol; 1999 Feb; 17 Suppl():BE20-1. PubMed ID: 10052319
[No Abstract] [Full Text] [Related]
13. Biotech's perfect storm.
Karberg S
Cell; 2009 Aug; 138(3):413-5. PubMed ID: 19665960
[TBL] [Abstract][Full Text] [Related]
14. Biotechnology consortia versus multifirm alliances: paradigm shift at work?
Persidis A; Persidis A
Nat Biotechnol; 1996 Dec; 14(13):1657-60. PubMed ID: 9634847
[No Abstract] [Full Text] [Related]
15. The changing norms of the life sciences.
Shorett P; Rabinow P; Billings PR
Nat Biotechnol; 2003 Feb; 21(2):123-5. PubMed ID: 12560827
[No Abstract] [Full Text] [Related]
16. Biotech firms jump on SARS bandwagon.
Basu P
Nat Biotechnol; 2003 Jul; 21(7):720. PubMed ID: 12833076
[No Abstract] [Full Text] [Related]
17. Overcoming the challenges in the pharma/biotech industry.
Graul AI; Prous JR
Drug News Perspect; 2007; 20(1):57-68. PubMed ID: 17332900
[TBL] [Abstract][Full Text] [Related]
18. What's fueling the biotech engine?
Aggarwal S
Nat Biotechnol; 2007 Oct; 25(10):1097-104. PubMed ID: 17921989
[No Abstract] [Full Text] [Related]
19. Little biotech on the prairie.
Wolfson W
Chem Biol; 2007 Sep; 14(9):969-71. PubMed ID: 17884626
[No Abstract] [Full Text] [Related]
20. Overcoming further challenges in the pharma/biotech industry: 2007 update.
Graul AI; Cruces E; Revel L; Serradell N; Rosa E
Drug News Perspect; 2008; 21(1):44-58. PubMed ID: 18301809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
